DeepGene damage signature
SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
84/100
vs baseline (day 0)
+10
1 improved · 8 worsened
synthetic signature · consistent with this patient's biology
- 3 opportunists above range: Escherichia coli, Streptococcus gallolyticus, Clostridioides difficile
- 5 keystone species absent
- Shannon 2.27 (expected ≥ 3)
- 9 resistance genes
- Host DNA fragmentation atypical
- Tissue recycling index 56
Pathogens / opportunists3/5
↓ from 4
Keystone species5/8
↑ from 4
Diversity2/2
Metabolic modules1/4
Vitamin synthesis4/7
↑ from 3
Oral translocation1/1
Host DNA1/1
↑ from 0
Tissue recycling1/1
Central mechanisms2/2
↑ from 1
Virulence factors5/5
↑ from 4
Antibiotic resistance genes9/9
↑ from 6
Genetic predisposition2/2
Opportunists above range
Escherichia coli 25.768% AR
Streptococcus gallolyticus 2.577% AR
Clostridioides difficile 2.577% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale, Faecalibacterium prausnitzii
Capacity
Shannon 2.27 · butyrate 414 CPM · SCFA 806
H2S above band
4 vitamins below
Host & mechanisms
host DNA fragmentation atypical
tissue recycling 56/100
oral translocation 5.85% AR
molecular_mimicry above
estrobolome above
9 resistance genes · 5 virulence factors
Import a sample
A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.
All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
| Escherichia coli | 20.444 % AR · above range | 25.768 % AR · above range | expected <= 1% | In excess raises LPS load and zonulin release, opening tight junctions. |
| Klebsiella pneumoniae | 0.014 % AR · in range | 0.194 % AR · in range | expected <= 0.3% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Enterococcus faecium | 10.222 % AR · above range | 0.222 % AR · in range(improved) | expected <= 0.5% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Streptococcus gallolyticus | 2.044 % AR · above range | 2.577 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Clostridioides difficile | 2.044 % AR · above range | 2.577 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
Keystone species · 8
| Akkermansia muciniphila | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Bifidobacterium longum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Butyricicoccus pullicaecorum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Eubacterium rectale | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Faecalibacterium prausnitzii | 1.32 % AR · in range | 0 % AR · absent(worsened) | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Lactobacillus species | 0.34 % AR · in range | 0.63 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Roseburia intestinalis | 1.31 % AR · in range | 1.29 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Ruminococcus bromii | 0.26 % AR · in range | 0.36 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
Diversity · 2
| indice Shannon | 2.45 · below range | 2.27 · below range | expected >= 3.0 | Low diversity: fewer reserve metabolic routes, slower recovery after perturbation. |
| numar de specii detectate | 98 specii · below range | 88 specii · below range | expected >= 100 | Species count below reference. |
Metabolic modules · 4
| Butyrate production | 537 CPM · in range | 414 CPM · in range | expected 255.83-1089.91 CPM | Butyrate is the main colonocyte fuel and barrier signal. |
| Short Chain Fatty Acid Production | 898 CPM · in range | 806 CPM · in range | expected 535.03-1572.59 CPM | Total SCFA capacity. |
| GABA production | 311 CPM · in range | 244 CPM · in range | expected 87.31-766.53 CPM | Gut–brain axis capacity. |
| H2S production (sulfate reduction) | 465 CPM · above range | 479 CPM · above range | expected banda de referinta | Hydrogen sulfide above band irritates the mucosa. |
Vitamin synthesis · 7
| Vitamin B1 - Thiamin | 176 CPM · below range | 537 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B2 - Riboflavin | 165 CPM · below range | 341 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B5 - Pantothenic acid | 282 CPM · below range | 251 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B6 - Pyridoxine | 2755 CPM · in range | 321 CPM · below range(worsened) | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B7 - Biotin | 2838 CPM · in range | 3905 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B9 - Folate | 3365 CPM · in range | 3631 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B12 - Cobalamin | 4316 CPM · in range | 3796 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
Oral translocation · 1
| Translocare orala (indice) | 4.65 % AR · above range | 5.85 % AR · above range | expected <= 2% | Oral taxa in stool: reduced gastric barrier or dysbiosis. |
Host DNA · 1
| fragmentare mixta | 156 pb · in range | 247 pb · atypical(worsened) | expected 150-170 pb | Host cell-free DNA fragmentation pattern. |
Tissue recycling · 1
| indice de reciclare tisulara | 48 /100 · above range | 56 /100 · above range | expected < 35 | Epithelial turnover. |
Central mechanisms · 2
| molecular_mimicry | 70 /100 · above range | 68 /100 · above range | expected < 65 | Cross-reactive antigen load. |
| estrobolome | 64 /100 · in range | 67 /100 · above range(worsened) | expected < 65 | Estrogen-recycling capacity. |
Virulence factors · 5
| fimD outer membrane usher | 21 potriviri/M · present | 43 potriviri/M · present | expected absent | Virulence factor detected. |
| chuA heme/hemoglobin receptor | 46 potriviri/M · present | 43 potriviri/M · present | expected absent | Virulence factor detected. |
| irp2 yersiniabactin synthetase | 34 potriviri/M · present | 92 potriviri/M · present | expected absent | Virulence factor detected. |
| espX4 type III secretion | 46 potriviri/M · present | 91 potriviri/M · present | expected absent | Virulence factor detected. |
| kpsD polysialic acid transport | — | 77 potriviri/M · present(new) | expected absent | Virulence factor detected. |
Antibiotic resistance genes · 9
| sul1 | 1.1 citiri/M · present | 4.4 citiri/M · present | expected nedetectat | Resistance gene detected. |
| sul2 | 8.7 citiri/M · present | 8 citiri/M · present | expected nedetectat | Resistance gene detected. |
| tet(O/M/O) | 5.1 citiri/M · present | 1.9 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Ecol_ampC_BLA | 1.3 citiri/M · present | 9.6 citiri/M · present | expected nedetectat | Resistance gene detected. |
| aadA | 10.9 citiri/M · present | 8.9 citiri/M · present | expected nedetectat | Resistance gene detected. |
| dfrA1 | 2.9 citiri/M · present | 1.1 citiri/M · present | expected nedetectat | Resistance gene detected. |
| APH(6)-Id | — | 3.8 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
| Erm(49) | — | 10.4 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
| msrC | — | 8 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
Genetic predisposition · 2
| FUT2 | 2.65 OR · risk variant | 2.74 OR · risk variant | expected reference genotype | Reduced mucosal fucosylation |
| CYP2D6 | 2.39 OR · risk variant | 1.94 OR · risk variant | expected reference genotype | Expected exposure |